Compare Centene Corp (CNC) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centene Corp vs Illumina, Inc. — how do they compare? Centene Corp trades at $65.13 (market cap $32.89B), while Illumina, Inc. trades at $193.06 (market cap $28.96B). The key difference: Centene Corp and Illumina, Inc. are close in size by market cap. Which is the better fit depends on your goals.
| CNC | ILMN | |
|---|---|---|
Market Cap | $32.89B | $28.96B |
Sector | Health | Health |
52-Week High | $68.72 | $205.10 |
52-Week Low | $26.17 | $91.00 |
Enterprise Value | $21.93B | $30.32B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
